Introducing and promoting HIV self-testing in West Africa
View More
Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.
Our grant projects apply the best that science has to offer to the fight against HIV/AIDS, tuberculosis, malaria, hepatitis C and co-infections in lower-resource countries.
Grant focus
HIV self-testing and prevention
Lead Grantee
Solthis
Status
Active
Amount
US$ 15.7 million
Disease
HIV
View More
Grant focus
HIV self-testing and prevention
Lead Grantee
London School of Hygiene and Tropical Medicine, MTV Staying Alive Foundation
Status
Active
Amount
US$ 10.1 million
Disease
HIV
View More
Grant focus
Overcome barriers to availability, quality and supply of medicines for severe malaria and malaria prevention
Lead Grantee
Medicines for Malaria Venture (MMV)
Status
Active
Amount
US $3,360,000
Disease
Malaria
View More
Grant focus
Provide effective oral prevention to young women in South Africa at high risk of HIV infection.
Lead Grantee
Wits Reproductive Health & HIV Institute
Status
Active
Amount
US $10,662,674
Disease
HIV
View More
Grant focus
To pilot long-lasting nets treated with new insecticide combinations in sub-Saharan African countries hardest hit by malaria
Lead Grantee
Innovative Vector Control Consortium (IVCC)
Status
Active
Amount
US$ 33 million
Disease
Malaria
View More
Grant focus
Collect data to determine whether a large-scale introduction of a malaria vaccine in Africa is workable.
Lead Grantee
World Health Organization
Status
Active
Amount
US $9,600,000
Disease
Malaria
View More
Grant focus
Provide pregnant women with intermittent doses of sulfadoxine-pyramethamine, a medicine that prevents malaria, and gather data on delivery through community health workers.
Lead Grantee
Jhpiego
Status
Active
Amount
US $49,653,329
Disease
Malaria
View More
Grant focus
Reach more children who are suffering from TB by using innovative models of TB care for children and improving the market for child-friendly TB medicines
Lead Grantee
Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)
Status
Active
Amount
US $36,346,541
Disease
Tuberculosis
View More